Epstein-Barr virus seroprevalence among inflammatory bowel disease patients in Saudi Arabia.

Badr Al-BawardyAbdulaziz F AlfadleyMohammed AlmousallamSaad AlShathriMohamed AboueissaAbdulrahman AlsulaimanMashary AttamimiAbdulelah AlMutairdi

Published in: Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association (2024)

In our cohort of IBD patients, 16.8% were naïve to EBV, and young age was a significant predictor of EBV non-exposure. Our data supports the practice of assessing EBV before initiating thiopurine therapy since EBV seroprevalence is not universal in our population.

Keyphrases

epstein barr virus
diffuse large b cell lymphoma
end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
peritoneal dialysis
prognostic factors
primary care
stem cells
artificial intelligence
patient reported
middle aged
quality improvement
replacement therapy